Harshad Kulkarni

Harshad Kulkarni

UNVERIFIED PROFILE

Are you Harshad Kulkarni?   Register this Author

Register author
Harshad Kulkarni

Harshad Kulkarni

Publications by authors named "Harshad Kulkarni"

Are you Harshad Kulkarni?   Register this Author

45Publications

-Reads

Influence of monsoonal recharge on arsenic and dissolved organic matter in the Holocene and Pleistocene aquifers of the Bengal Basin.

Sci Total Environ 2018 Oct 10;637-638:588-599. Epub 2018 May 10.

Department of Chemistry, University of Kalyani, Kalyani, Nadia, West Bengal, India.

View Article
October 2018

Ten-Year Survival After Peptide Receptor Radionuclide Therapy of a Metastatic Well-differentiated G3 Pancreatic Neuroendocrine Neoplasm.

Clin Nucl Med 2018 Sep;43(9):676-678

From the THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
September 2018

Water Recovery from Advanced Water Purification Facility Reverse Osmosis Concentrate by Photobiological Treatment Followed by Secondary Reverse Osmosis.

Environ Sci Technol 2018 Aug 9;52(15):8588-8595. Epub 2018 Jul 9.

Department of Environmental Sciences , University of California , Riverside , California 92521 , United States.

View Article
August 2018

Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.

J Nucl Med 2018 Aug 16. Epub 2018 Aug 16.

THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Zentralklinik Bad Berka.

View Article
August 2018

Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen.

Br J Radiol 2018 Jun 1:20180308. Epub 2018 Jun 1.

1 Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka , Bad Berka , Germany.

View Article
June 2018

Results and adverse events of personalized peptide receptor radionuclide therapy with Yttrium and Lutetium in 1048 patients with neuroendocrine neoplasms.

Oncotarget 2018 Mar 15;9(24):16932-16950. Epub 2018 Feb 15.

Department of Gastroenterology/Endocrinology, Center for Neuroendocrine Tumors Bad Berka - ENETS Center of Excellence, Zentralklinik Bad Berka GmbH, Bad Berka, Germany.

View Article
March 2018

Injection of Botulinum Toxin for Preventing Salivary Gland Toxicity after PSMA Radioligand Therapy: an Empirical Proof of a Promising Concept.

Nucl Med Mol Imaging 2018 Feb 11;52(1):80-81. Epub 2018 Jan 11.

1Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
February 2018

Dissolved fulvic acids from a high arsenic aquifer shuttle electrons to enhance microbial iron reduction.

Sci Total Environ 2018 Feb 17;615:1390-1395. Epub 2017 Oct 17.

INSTAAR, University of Colorado at Boulder, Boulder, CO 80302, USA; Department of Biology, Duke University, Durham, NC 27708, USA.

View Article
February 2018

Theranostics of Neuroendocrine Tumors.

Visc Med 2017 Oct 20;33(5):358-366. Epub 2017 Oct 20.

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
October 2017

Theranostic Prospects of Gastrin-Releasing Peptide Receptor-Radioantagonists in Oncology.

PET Clin 2017 Jul 3;12(3):297-309. Epub 2017 Apr 3.

Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka 99497, Germany.

View Article
July 2017

Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases.

Neuroendocrinology 2018 21;106(1):74-88. Epub 2017 Jul 21.

Department of Radiology, University Hospitals of Beaujon, Clichy, France.

View Article
July 2017

First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced Sc-DOTATOC: A Proof-of-Concept Study.

Cancer Biother Radiopharm 2017 May;32(4):124-132

1 Theranostics Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence , Zentralklinik Bad Berka, Germany .

View Article
May 2017

Rapid Synthesis of Ga-labeled macroaggregated human serum albumin (MAA) for routine application in perfusion imaging using PET/CT.

Appl Radiat Isot 2017 Apr 9;122:72-77. Epub 2017 Jan 9.

Department of Nuclear Medicine, University Hospital Halle(Saale), Germany.

View Article
April 2017

Imaging of Prostate Cancer Using Cu-Labeled Prostate-Specific Membrane Antigen Ligand.

PET Clin 2017 Apr 31;12(2):193-203. Epub 2017 Jan 31.

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging (PET/CT), ENETS Center of Excellence, Zentralklinik Bad Berka, Robert-Koch-Allee 9, Bad Berka 99437, Germany.

View Article
April 2017

Phase 3 Trial of Lu-Dotatate for Midgut Neuroendocrine Tumors.

N Engl J Med 2017 01;376(2):125-135

From the Moffitt Cancer Center, Tampa, FL (J.S., G.E.-H.); Markey Cancer Center, University of Kentucky, Lexington (E.W.); Cedars Sinai Medical Center, Los Angeles (A.H.), and Stanford University School of Medicine, Stanford (E.M., P.L.K.) - both in California; University of Texas M.D. Anderson Cancer Center (J.Y., B.C.) and Excel Diagnostics Imaging Clinic (E.D.), Houston; Dana-Farber Cancer Institute, Boston (M.H.K., H.J.); University of Iowa, Iowa City (D.B., T.M.O.); Zentralklinik, Bad Berka (R.P.B., H.R.K.), and Charité-Universitätsmedizin, Berlin (M.P.) - both in Germany; Royal Free Hospital (M.C.) and King's College Hospital NHS Foundation Trust (R.S.), London, and Beatson Oncology Centre, Glasgow (N.R.) - all in the United Kingdom; Hôpital Beaujon, Clichy (R.L., P.R.), and Advanced Accelerator Applications, St. Genis-Pouilly (T.T.) - both in France; Mayo Clinic College of Medicine, Rochester, MN (T.H.); University Hospitals and KU Leuven, Leuven, Belgium (E.V.C.); Robert H. Lurie Comprehensive Cancer Center, Chicago (A.B.); Hospital Universitari de Bellvitge, Barcelona (J.M.), and Hospital Universitario Ramón y Cajal, Madrid (E.G.) - both in Spain; Vanderbilt University Medical Center, Nashville (J.B.); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan (E.S.); University Hospital, Uppsala University, Uppsala, Sweden (K.O.); Advanced Accelerator Applications USA, New York (M.L.S., P.S., J.L.E.); and Erasmus Medical Center, Rotterdam, the Netherlands (D.K., E.K.).

View Article
January 2017

PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: The Bad Berka Experience Since 2013.

J Nucl Med 2016 Oct;57(Suppl 3):97S-104S

Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany

View Article
October 2016

Advances in the Diagnosis of Neuroendocrine Neoplasms.

Semin Nucl Med 2016 09;46(5):395-404

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany. Electronic address:

View Article
September 2016

Malignant presacral ghrelinoma with long-standing hyperghrelinaemia.

Ups J Med Sci 2015 20;120(4):299-304. Epub 2015 Jun 20.

e 5 Department of Pathology, County Hospital Ryhov , Jönköping, Sweden.

View Article
August 2016

Peptide Receptor Radionuclide Therapy (PRRT) of Medullary and Nonmedullary Thyroid Cancer Using Radiolabeled Somatostatin Analogues.

Semin Nucl Med 2016 May;46(3):215-24

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Germany. Electronic address:

View Article
May 2016

Companion Diagnostics and Molecular Imaging.

Cancer J 2015 May-Jun;21(3):213-7

From the Theranostics Center for Molecular Radiotherapy and Molecular Imaging (PET/CT), ENETS Center of Excellence, Zentralklinik Bad Berka, Germany.

View Article
February 2016

Localization of Radiolabeled Somatostatin Analogs in the Spleen.

Clin Nucl Med 2016 Feb;41(2):e111-4

From the *Department of Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands; †Department of General and Visceral Surgery, and ‡Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka; §Institute of Pharmacology and Toxicology, Jena University Hospital, Jena; ∥Laboratory of Pathology and Cytology, Zentralklinik Bad Berka, Bad Berka, Germany; and ¶Department of Radiology, Erasmus MC, Rotterdam, the Netherlands.

View Article
February 2016

Peptide receptor radionuclide therapy with (90)Y/ (177)Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours).

Eur J Nucl Med Mol Imaging 2015 Jul 31;42(8):1223-30. Epub 2015 Mar 31.

THERANOSTICS Centre for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Robert Koch Allee, Bad Berka, 99437, Germany.

View Article
July 2015

First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with (68)Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3 Integrin Receptor Targeting.

Cancer Biother Radiopharm 2015 May;30(4):152-9

1 THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, ENETS Center of Excellence , Bad Berka, Germany .

View Article
May 2015

Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT.

PET Clin 2014 Jan;9(1):83-90

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Robert-Koch-Alle 9, 99437 Bad Berka, Germany.

View Article
January 2014

Theranostics with Ga-68 somatostatin receptor PET/CT: monitoring response to peptide receptor radionuclide therapy.

PET Clin 2014 Jan 19;9(1):91-7. Epub 2013 Oct 19.

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, 99437 Bad Berka, Germany.

View Article
January 2014

THERANOSTICS-clinical aimshots in surgical warfare against well-differentiated neuroendocrine neoplasms.

Ann Transl Med 2014 Jan;2(1)

1 Internal Medicine/Gastroenterology and Endocrinology, Center for Neuroendocrine Tumors Bad Berka-ENETS Center of Excellence, Zentralklinik Bad Berka GmbH, Robert-Koch-Allee 9, 99437 Bad Berka, Germany ; 2 THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, Center for Neuroendocrine Tumors Bad Berka-ENETS Center of Excellence, Zentralklinik Bad Berka GmbH, Robert-Koch-Allee 9, 99437 Bad Berka, BRD, Germany.

View Article
January 2014

Peptide receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)Yttrium and (177)Lutetium labeled somatostatin analogs: toxicity, response and survival analysis.

Am J Nucl Med Mol Imaging 2013 15;4(1):39-52. Epub 2013 Dec 15.

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence Zentralklinik Bad Berka, Germany.

View Article
December 2013

High uptake of (68)Ga-DOTATOC in spleen as compared to splenosis: measurement by PET/CT.

Recent Results Cancer Res 2013 ;194:373-8

Department of Nuclear Medicine, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
June 2013

Rare metastases detected by (68)Ga-somatostatin receptor PET/CT in patients with neuroendocrine tumors.

Recent Results Cancer Res 2013 ;194:379-84

Department of Nuclear Medicine, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
June 2013

Peptide receptor radionuclide therapy with (177)Lu labeled somatostatin analogs DOTATATE and DOTATOC: contrasting renal dosimetry in the same patient.

Recent Results Cancer Res 2013 ;194:551-9

Department of Nuclear Medicine and Center for PET/CT, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
June 2013

Is there a correlation between peptide receptor radionuclide therapy-associated hematological toxicity and spleen dose?

Recent Results Cancer Res 2013 ;194:561-6

Department of Nuclear Medicine/Center for PET/CT, ENETS Center of Excellence Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
June 2013

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience.

Theranostics 2012 7;2(5):437-47. Epub 2012 May 7.

Department of Nuclear Medicine/ Center for PET/CT, Zentralklinik Bad Berka, ENETS Center of Excellence, Zentralklinik Bad Berka, 99437 Bad Berka, Germany.

View Article
October 2012

Ga-68 Somatostatin Receptor PET/CT in von Hippel-Lindau Disease.

Nucl Med Mol Imaging 2012 Jun 27;46(2):129-33. Epub 2012 Apr 27.

Department of Nuclear Medicine and Center for PET/CT, Zentralklinik Bad Berka, 99437 Bad Berka, Germany.

View Article
June 2012

Peptides and receptors in image-guided therapy: theranostics for neuroendocrine neoplasms.

Semin Nucl Med 2012 May;42(3):190-207

Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
May 2012

Molecular imaging with ⁶⁸Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours.

Eur J Nucl Med Mol Imaging 2011 Sep 31;38(9):1659-68. Epub 2011 May 31.

Department of General and Visceral Surgery, Zentralklinik Bad Berka GmbH, Robert-Koch-Allee 9, 99437 Bad Berka, Germany.

View Article
September 2011